Posted by Michael Wonder on 01 Sep 2019
Schedule of Pharmaceutical Benefits - 1 September 2019 update
1 September 2019 - The September 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The September issue of the Schedule includes a few new listings:
- Botulinum toxin type A (Botox) - new indication
- Buprenorphine (Buvidal) - new formulation
- Morphine sulphate (Kapanol) - new indication
- Nivolumab (Opdivo) - restriction change
